Survival analyses showed that PACA patients who had higher expression levels of MBOAT2/CDA/LPCAT2/B4GALT5 had shorter overall survival rates. This evidence concerns the gene B4GALT5 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.